Professional Documents
Culture Documents
Congenital Acyanotic Heart Disease
Congenital Acyanotic Heart Disease
Congenital Acyanotic Heart Disease
Disease
• Prevalence: 8 per 1000 live births
• Aetiopathogenesis:
• Unknown mostly
• Chromosomal anomaly (Down Syndrome,
Turner Syndrome)
• Antenatal illness of mothers (DM, Rubella
infection, radiation)
Acyanotic Congenital Heart Disease
Left-to-Right Shunt Lesions
• Aortic Stenosis
• Small VSD: -
No surgical intervention, no physical restrictions, just reassurance and periodic
follow-up and endocarditis prophylaxis.
•Moderate to Large VSD (Medical treatment):
•High calorie diet for proper nutrition
•Afterload reducers ( Captopril, Enalapril)
• Diuretics (Frusemide)
•Control of heart failure
• Digoxin if needed.
•
Surgical Treatment
• Indications for Surgical Closure:
• Large VSD with medically uncontrolled
symptomatology & continued FTT.
• Ages 6-12 mo with large VSD & Pulm. HTN
• Age > 24 mo with Qp:Qs ratio > 2:1.
• Supracristal VSD of any size, secondary to risk of
developing AV insufficiency.
• Contraindication:
Severe pulmonary vascular disease.
Prognosis
• Answer:
Systolic murmur is caused by increased flow across the
pulmonary valve, NOT THE ASD.
•Medical treatment:
•High calorie diet for proper nutrition
•Afterload reducers ( Captopril, Enalapril)
• Diuretics (Frusemide)
•Digoxin if needed.
•Surgical Treatment:
Closer of the defect.
Atrial Septal Defect
• Question:
Is endocarditis prophylaxis required for
ASD?
• Answer:
NO
Patent Ductus Arteriosus
• Answer:
Rubella
Patent Ductus Arteriosus
Hemodynamics
• As a result of higher aortic pressure, blood shunts
L to R through the ductus from Aorta to PA.